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Obstructive sleep apnea (OSA) predominantly during rapid eye movement (REM) sleep 
may have impacts on brain health, even in milder OSA cases. Here, we evaluated whether 
REM sleep OSA is associated with abnormal daytime cerebral functioning using high-
resolution single-photon emission computed tomography (SPECT). We tested 96 subjects 
(25F, age: 65.2 ± 6.4) with a wide range of OSA severity from no OSA to severe OSA 
(apnea-hypopnea index: 0-97 events/hour). More respiratory events during REM sleep were 
associated with reduced daytime regional cerebral blood flow (rCBF) in the bilateral 
ventromedial prefrontal cortex and in the right insula extending to the frontal cortex. More 
respiratory events during non-REM (NREM) sleep were associated with reduced daytime 
rCBF in the left sensorimotor and temporal cortex. In subjects with a lower overall OSA 
severity (apnea-hypopnea index<15), more respiratory events during REM sleep were also 
associated with reduced daytime rCBF in the insula and extending to the frontal cortex. 
Respiratory events that characterized OSA during NREM versus REM sleep are associated 
with distinct patterns of daytime cerebral perfusion. REM sleep OSA could be more 
detrimental to brain health, as evidenced by reduced daytime rCBF in milder forms of 
OSA. Keywords: Functional neuroimaging; Perfusion; REM-predominant OSA; Sleep-




Previous studies using quantitative neuroimaging techniques have shown that obstructive 
sleep apnea (OSA) is associated with altered daytime cerebral functioning over many 
different cortical and subcortical regions.1-6 Impacts of OSA on brain function also include 
daytime sleepiness and altered mood.7 Recent studies showed that OSA increases the risk 
of accelerated cognitive decline and dementia.8 Improving our understanding of how OSA 
causes daytime cerebral dysfunctions, particularly in older individuals, is needed to identify 
patients at risk of adverse long-term neurocognitive consequences.  
The sleep stage during which apneas and hypopneas occur might significantly affect how 
OSA will impact daytime cerebral functioning. About 14 to 37 % of individuals with OSA 
have most of their apneas and hypopneas during rapid-eye movement (REM) sleep, and this 
proportion is higher for milder OSA cases.9-13 Because REM sleep represents only a small 
proportion of total sleep duration, many respiratory events predominantly during REM 
sleep may still result in a low overall apnea-hypopnea index (AHI), leading to a milder 
OSA diagnosis. This poses a clinical dilemma as to whether we should treat milder OSA 
cases that features respiratory events predominantly during REM sleep.14 This dilemma can 
only be resolved if we understand the specific impact of OSA during REM sleep versus 
non-REM (NREM) sleep on general health. Aiming at answering this question, previous 
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studies have shown that obstructive respiratory events during REM sleep are generally 
longer, more hypoxic and cause higher blood pressure elevation than those occurring in 
NREM sleep.15, 16 OSA during REM sleep was also repeatedly associated with 
cardiovascular and metabolic consequences, including a higher incidence of 
hypertension,17, 18 loss of nighttime blood pressure dipping,19 poor glycemic control in type 
2 diabetes patients,20 and insulin resistance.21 Because all these conditions may affect the 
brain functioning, these recent discoveries suggest that REM sleep OSA may be especially 
detrimental to brain health.  
The present study aimed at determining whether respiratory events, i.e., apneas and 
hypopneas, during REM sleep are associated with abnormal daytime cerebral functioning. 
To achieve this goal, the association between OSA during REM versus NREM sleep was 
investigated with single photon emission computed tomography (SPECT) during 
wakefulness to measure regional cerebral blood flow (rCBF), as this technique was shown 
to be sensitive to cerebral changes in OSA.1 Resting-state cerebral perfusion is considered a 
marker of brain functioning because it is closely related to neuronal and astroglial activity 
via the neuro-vascular coupling.22 We hypothesized that 1) the severity of OSA during 
REM versus NREM sleep would be characterized by distinct daytime rCBF patterns, and 
that 2) OSA during REM sleep would be associated with daytime rCBF anomalies even in 
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milder cases for whom there is a clinical dilemma. Additional daytime cerebral functioning 
measurements were used to assess sleepiness, mood, and cognition. 
 
MATERIAL AND METHODS 
Recruitment  
We recruited subjects aged between 55 and 85 years old with a wide range of OSA 
severities from ads in media, although some subjects (n=21) were recruited from a waiting 
list for OSA screening in a pulmonary clinic. Recruitment continued until all OSA severity 
groups (from healthy controls to severe OSA individuals) were represented. Exclusion 
criteria were psychiatric (e.g., diagnosed depression and anxiety disorders), neurologic 
(e.g., dementia, stroke) and pulmonary diseases (e.g. chronic obstructive pulmonary 
disease); sleep disorders other than OSA (e.g., restless leg syndrome, insomnia, rapid-eye 
movement sleep behavior disorder, parasomnias); morbid obesity (≥ 40 kg/m2); drug and 
alcohol abuse; and medications known to influence sleep or cerebral functioning (e.g., 
antidepressants, benzodiazepines, opioids, antiepileptics, antipsychotics). Cardiovascular 
risk factors and diseases were assessed with the Index of Vascular Burden.23 Participants 
with controlled diabetes or hypertension were not excluded, but their conditions were 
documented in that index. All OSA subjects included in our study were newly diagnosed 
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and none of them were treated for OSA. The Hôpital du Sacré-Coeur de Montréal Ethics’ 
Committee approved the research protocol (#2012-697). The present research and the 
Ethics’ Committee follow the guidelines of the Canadian Tri-Council Policy Statement: 
Ethical Conduct for Research and Involving Humans, as well as the Declaration of 
Helsinki. Written informed consent was obtained from each participant.  
Overview of the protocol 
Participants were evaluated with a polysomnographic recording, questionnaires, and a 
SPECT imaging session. In order to characterize our sample, we used questionnaires, 
namely Epworth Sleepiness Scale (ESS);24 Beck Depression Inventory-II (BDI-II);25 Beck 
Anxiety Inventory (BAI);26 and a cognitive screening test, the Montreal Cognitive 
Assessment (MoCA).27 Questionnaires were administered the evening before 
polysomnography, except for the MoCA that was performed the morning after by a trained 
neuropsychologist. The daytime SPECT imaging was performed a month on average after 
the polysomnographic recording (26.2 ± 30.2 days). 
Polysomnographic recording 
The full-night polysomnographic recording was performed in a sleep laboratory and 
included an 18-channel electroencephalogram, an electrooculogram, chin and anterior 
tibialis electromyograms, and an electrocardiogram. Apneas and hypopneas were recorded 
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with thoracic-abdominal strain gauges, oronasal cannula and thermal sensors, and a 
transcutaneous finger pulse oximeter. Sleep stages as well as apneas and hypopneas were 
scored by a medical electrophysiology technologist with extensive training in sleep 
according to the 2007 American Academy of Sleep Medicine Manual for the scoring of 
sleep28 and their 2012 update for the scoring of respiratory events.29. Apneas and 
hypopneas were scored if they lasted >10 s. An airflow reduction of ≥90  % and ≥30  % 
defined an apnea and a hypopnea, respectively. A hypopnea had to be accompanied by 
either an oxygen desaturation of ≥3  % or an arousal.  
The REM-AH was computed by adding the total number of apneas and hypopneas during 
REM sleep (and vice versa for NREM-AH). The REM-AHI was calculated as follows: 
apneas+hypopneas during REM sleep / REM sleep duration in hours (and vice versa for 
NREM-AHI). Apneas and hypopneas that occurred either completely or partially during 
REM sleep were computed in the REM-AH and REM-AHI, while others were computed in 
the NREM-AH and NREM-AHI. Although these variables include central events, all OSA 
participants had mostly obstructive rather than central events (9.8 ± 15.0  % of the AHI 
were central events).  
SPECT image acquisition, processing, and data analysis 
To assess rCBF during wakefulness, all subjects underwent technetium-99m-
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hexamethylpropyleneamine oxime (99mTc-HMPAO) SPECT scanning using a high-
resolution brain-dedicated scanner (NeuroFOCUS, NeuroPhysics, Shirley, USA). This 
procedure was described in a previous study by our group.1 While subjects lay awake with 
their eyes closed, an average dose of 750 MBq of 99mTc-HMPAO was administered 
intravenously followed by a saline flush. 99mTc-HMPAO uptake in the brain takes about a 
minute. This fast uptake allows reducing to a maximum the potential effect of drowsiness 
on scanning. Twenty minutes later, projections were acquired statically for 30 minutes. 
Individual images were reconstructed in a 128 x 128 matrix to achieve 32 slices with a 
filtered back projection and an attenuation correction (Chang’s absorption coefficient: 0.01 
cm-1). Because this SPECT scanner does not record the whole cerebellum, this region was 
excluded from analyses. All acquired individual images were visually inspected for gross 
abnormalities. Individual SPECT images were registered and spatially normalized (co-
registered and warped) to the standard SPECT template included in SPM8 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). Normalized images were smoothed 
using a 14-mm full-width half-maximum filter and proportionally scaled with a grand mean 
scaling of 50 ml/min/100g for individual global mean signals. Therefore, rCBF changes are 
relative to the mean of each subject rather than absolute rCBF changes. This grand mean 
scaling allows reducing inter-individual variations regarding the amount of radioactivity 
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detectable. Final individual images were equally smoothed and normalized into the same 
common space in order to performed voxel-based statistical comparisons. 
Statistical analyses 
Statistics were performed with SPSS 19 (IBM SPSS Statistics, New York, USA), except 
for rCBF analyses that were performed within SPM. Comparisons between control, mild, 
moderate and severe OSA groups were performed with one-way ANOVA for continuous 
variables and chi-square for categorical variables. These variables included clinical, 
demographic, polysomnographic and cognitive data (see Table 1).  
Use of a regression approach in REM sleep OSA 
We assessed the relationship between REM sleep OSA and daytime cerebral functioning 
mostly using regression models. Although groups are clinically important, there is many 
different criteria that exist in the current literature with arguably arbitrary cut-offs to define 
the presence of REM sleep OSA.10 Moreover, some studies showed a dose-response 
relationship between various physiological functions and respiratory events during REM 
sleep.18-21 Regression models are not limited by arbitrary cut-offs and may represent more 
closely the physiopathology compared to a group analysis. Regressions models used in the 
present study were based on those performed in large cohort studies that have investigated 
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the effect of REM sleep OSA on hypertension, glucose metabolism as well as sleepiness 
and quality of life.18, 19, 21, 30 
 
Independent variables for statistical models  
The relationship between REM sleep OSA and daytime cerebral functioning is evaluated 
with statistical models presented below. REM sleep OSA was assessed with the REM-AHI 
and the REM-AH. Because REM sleep duration is the denominator to compute the REM-
AHI, a very short duration may lead to an overestimation of REM sleep OSA. Therefore, 
for analyses using the REM-AHI, subjects with very short REM sleep duration (<30 
minutes) during their polysomnographic recording were excluded. This threshold was used 
in previous studies investigating the impacts of REM sleep OSA.17, 18 Moreover, the REM-
AHI is highly dependent of the REM sleep duration whether it is very short or very long. 
Because the REM-AHI is limited by the REM sleep duration to accurately assessed OSA 
during REM sleep, we also performed statistical models with the REM-AH instead of the 
REM-AHI. With models performed with the REM-AH, all subjects were included 
regardless of REM sleep duration since there is no denominator effect. Thus, subjects with 
less than 30 minutes of REM sleep were included in all analyses with the REM-AH. 
However, total sleep time was included as a covariate in regression models with the REM-
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AH to adjust for sleep duration. Indeed, because total sleep time and REM sleep duration 
are highly correlated, including total sleep time in models partially adjust for REM sleep 
duration.  
Respiratory variables representing OSA were negatively skewed, did not have a normal 
distribution, and contained at least one value equal to zero. Thus, the formula 
“log10(variable + 1)” was used. Similar data transformation for regression models was used 
in previous studies investigating the impacts of REM sleep OSA.18-21, 30 Statistics that were 
performed between variables included in regression models suggested no multicollinearity 
(variance inflation factor <1.1). Age was included as a covariate in all models. Because the 
prevalence of REM sleep OSA is reported to be closely associated with sex,12 we did not 
include it as a covariate upfront since it could have removed an REM sleep OSA effect. 
We, however, performed supplementary analyses that included both age and sex as 
covariates for each statistical model.  
Model 1: Regression between REM sleep OSA and daytime rCBF in all subjects 
To assess whether OSA during REM versus NREM sleep is associated with distinct 
patterns of daytime cerebral functioning, linear regressions were used across all subjects 
from controls to severe OSA individuals. Since both REM and NREM sleep OSA variables 
were included in the same model simultaneously (REM-AH and NREM-AH, or REM-AHI 
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and NREM-AHI), significant regressions with REM sleep OSA were controlled for NREM 
sleep OSA, and vice versa. This allowed investigating OSA effect during each sleep type 
independently on daytime rCBF as a dependent variable. In a supplementary analysis, we 
also divided the sample into quartiles of REM sleep OSA severity and compared them 
regarding their daytime rCBF values (see Model S1 in supplementary material online). 
Model 2: Regression between REM sleep OSA and daytime rCBF in subjects with an 
AHI<15 
OSA that is predominantly during REM sleep can result in a low overall OSA severity. To 
assess whether REM sleep OSA affects daytime cerebral functioning in milder OSA 
severity, REM and NREM sleep OSA variables (REM-AH and NREM-AH, or REM-AHI 
and NREM-AHI) were included simultaneously in a regression model with daytime rCBF 
as a dependent variable in subjects with an AHI<15 only, thus excluding subjects with an 
overall moderate and severe OSA. We also investigated the association between daytime 
rCBF and REM sleep OSA in subjects with no or mild NREM sleep OSA in a 
supplementary analysis (NREM-AHI <15, see Model S2 in supplementary material online).  
Model 3: Regression between REM sleep OSA and symptomatology 
To investigate whether REM sleep OSA (or NREM sleep OSA) is associated with global 
cognitive performance, depressive and anxious symptoms or with daytime sleepiness, we 
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performed regression analyses across all subjects including both REM sleep and NREM 
sleep OSA variables simultaneously in regression models (REM-AH and NREM-AH, or 
REM-AHI and NREM-AHI) with MoCA, BDI-II, BAI and ESS as dependent variables.  
Statistical thresholds 
For daytime rCBF analyses performed within SPM, models were applied with the voxel-
based technique. Final processed individual SPECT images have thousands of rCBF 
values: one single rCBF value for every voxel (2 mm3). This type of neuroimaging 
technique applies the statistical models on all voxels specified. We used a mask covering 
gray matter in the cerebrum to apply constructed models on these voxels only, thus 
excluding the cerebellum, the white matter and cerebrospinal fluid. Significance was set at 
p <0.001 for voxel peaks combined with an extent threshold of clusters containing ≥100 
contiguous voxels. This specific combination of a liberal p-value uncorrected for multiple 
comparisons combined with a restrictive cluster size was shown to better find and localizes 
regions with changed metabolism, without increasing false positives.31 Significant regions 
were identified using PickAtlas with the Automated Anatomical Labeling (AAL) atlas 
(http://fmri.wfubmc.edu/software/pickatlas; version 3.0). For exploratory analyses with 





The sample included 96 subjects (25 females; 71 males; mean age: 65.2 ± 6.4 years; age 
range: 55-82 years). In order to describe our sample, we divided subjects into four groups 
according to their AHI: control group (17% of the sample) and mild (38%), moderate 
(21%), and severe (24%) OSA groups. Detailed participant characteristics are presented in 
Table 1. At study entry, 44% of the sample reported an OSA-related complaint, including 
snoring, daytime sleepiness or bed partner witnessing respiratory disturbances. The average 
apnea and hypopnea duration as well as mean and minimal oxygen saturation did not differ 
significantly between REM and NREM sleep in our sample. 
No differences were found between controls and OSA groups for sleepiness, mood, or 
cognition. In our sample, around a third presented daytime sleepiness (33% with Epworth 
Sleepiness Scale ≥10), whereas about a fifth presented cognitive deficits (21% with the 
Montreal Cognitive Assessment <26). Low levels of depression and anxiety (9% with Beck 
Depression Inventory ≥14 and 16% with Beck Anxiety Inventory ≥10) were observed. No 




Model 1: Regression between REM sleep OSA and daytime rCBF in all subjects 
In all subjects (n=96) including those with less than 30 minutes of REM sleep, the REM-
AH and NREM-AH were associated independently with distinct patterns of reduced 
daytime rCBF (see Figure 1 and Table 2). Reduced daytime rCBF was observed in 
association with REM-AH in the bilateral ventromedial prefrontal cortex and the right 
insula extending to the inferior frontal gyrus. Reduced daytime rCBF with NREM-AH was 
present in the left sensorimotor cortex and left lateral temporal cortex. No region of 
increased daytime rCBF was observed. When sex was added as a covariate, a similar 
pattern of hypoperfusion was observed with REM-AH whereas no daytime rCBF changes 
were observed with NREM-AH (see Table 2). 
We performed the same model with REM-AHI and NREM-AHI (instead of REM-AH and 
NREM-AH) in subjects with an REM sleep duration ≥30 minutes (n=84). Of the 96 
subjects recruited, 12 subjects had <30 minutes of REM sleep during their in-laboratory 
polysomnographic recording. As stated earlier, a very short REM sleep duration led to a 
very high REM-AHI and therefore, an overestimation of OSA during REM. These subjects 
with short REM sleep duration had a higher AHI (p <0.05) and shorter total sleep time (p 
<0.001) than subjects with more than 30 minutes of REM sleep. Unsurprisingly, subjects 
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with short REM sleep duration had a higher REM-AHI compared to other subjects (64.6 
events/hour versus 24.9 events/hour respectively, p <0.001).  
Distinct patterns of daytime rCBF were also associated with REM-AHI and NREM-AHI. 
Reduced daytime rCBF in the right medial orbitofrontal cortex was associated with REM-
AHI, and reduced daytime rCBF in the left postcentral gyrus was correlated with NREM-
AHI. Therefore, the same regions of hypoperfusion were found with the absolute amount of 
AHs than with the AHIs. However, less and smaller clusters were found with REM-AHI 
and NREM-AHI compared to analyses performed in the complete sample with REM-AH 
and NREM-AH (see Table 2).  
In our quartiles supplementary analysis, similar regions of daytime hypoperfusion (frontal 
cortex, insula and basal ganglia) were observed in the second and fourth quartiles of REM 
sleep OSA compared to the first quartile (see Model S1 in supplementary material online). 
Model 2: Regression between REM sleep OSA and daytime rCBF in subjects with an 
AHI<15 
In subjects with an overall OSA severity considered as no or mild OSA (n=54), including 
those with REM sleep duration <30 minutes, the REM-AH was associated with reduced 
daytime rCBF in the bilateral insula extending to the inferior frontal gyrus on the right 
hemisphere, adjusted for NREM-AH, age and total sleep duration (see Table 2). Similar 
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results on the right hemisphere were observed when sex was entered as a covariate or when 
the REM-AHI was used instead in subjects with a REM sleep duration ≥30 minutes (see 
Table 2). No region of increased daytime rCBF was found, and no association was 
observed between daytime rCBF and NREM-AH. 
In our supplementary analysis, similar regions of daytime hypoperfusion (frontal cortex and 
insula) were observed with REM sleep OSA in subjects with either no or mild NREM sleep 
OSA (see Model S2 in supplementary material online). 
Model 3: Regression between REM sleep OSA and symptomatology 
In the complete sample (n=96) including those with REM sleep duration <30 minutes, only 
a trend was observed: a higher REM-AH was associated with a worse MoCA (r=-0.197, 
p=0.06) when adjusting for NREM-AH, age and total sleep time. When sex was entered as 
a covariate, the same trend remained (r=-0.206, p=0.05). No association was found with the 
BDI-II, BAI and ESS scores with REM-AH, and no association was found between any 
questionnaire score and the NREM-AH.  
In the sample corresponding to either no or mild OSA (AHI<15, n=54), including those 
with REM sleep duration <30 minutes, a trend was found with a higher REM-AH 
associated with more depressive symptoms (r=0.261, p=0.07). However, that trend was not 
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present when adjusted for sex. No association was found between NREM-AH and any 
questionnaire score. No association was found with the MoCA, BAI and ESS scores.  
None of these trends were observed with the REM-AHI in subjects with a REM sleep 
duration ≥30 minutes instead of the REM-AH adjusted for total sleep duration. 
 
DISCUSSION 
Summary of the cerebral perfusion findings 
In this study, we aimed to clarify the impacts of OSA during REM sleep on daytime 
cerebral functioning. We found that more respiratory events during REM or NREM sleep 
are associated with different patterns of daytime brain perfusion. In fact, the presence of 
more apneas and hypopneas during REM sleep was associated with daytime hypoperfusion 
in the ventromedial prefrontal and fronto-insular regions, whereas more respiratory events 
during NREM sleep was associated with daytime hypoperfusion in the left sensorimotor 
and temporal cortex. Another significant finding is that reduced daytime brain perfusion 
was also observed in fronto-insular regions in association with REM sleep OSA among 
subjects without moderate to severe OSA. This result suggests that when the overall OSA 
severity is low, REM sleep OSA can still affect daytime cerebral functioning, a finding that 
was not observed for NREM sleep OSA. This also suggests that the presence of REM sleep 
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OSA exclusively can affect daytime cerebral functioning. The novelty of our study lies in 
the use of neuroimaging to investigate whether REM sleep OSA affects daytime cerebral 
functioning in a large sample of participants, including subjects with milder forms of OSA.  
SPECT as a sensitive tool to detect cerebral dysfunctions in OSA  
Resting-state cerebral perfusion is considered as a marker of brain functioning because it is 
closely related to neuronal and astroglial activity,22 although other contributing factors to 
cerebral perfusion include vascular reactivity and cerebral autoregulation.32 Because 
neurovascular coupling was reported to be preserved in OSA individuals,33 we can 
hypothesize that altered daytime rCBF represent, in part at least, metabolic demands of 
neurons and astrocytes. Hypoperfusions in the ventral, medial and orbital prefrontal cortex, 
as well as in the insula were found in previous OSA studies.1, 2, 4-6 Similarly, reduced rCBF 
in temporal and sensorimotor regions were also reported in OSA subjects.1-3, 5, 6 Therefore, 
our study brings new insight into the discrepancies across brain regions that have been 
reported as hypoperfused in previous OSA studies: differences in the numbers of apneas 
and hypopneas during REM and NREM sleep could explain why different brain locations 
show abnormal daytime rCBF in different studies.  
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Characteristics of OSA during REM sleep and daytime cerebral functioning 
During REM sleep, upper airway muscle activity is reduced and their collapsibility 
increases,10, 18, 34 which may lead to more apneas and hypopneas during REM sleep, even in 
milder OSA cases. The literature is scarce on the consequences of REM sleep OSA with a 
mild overall severity. In addition, it is unclear whether these patients should they be treated 
or not.14 Our results showed that REM sleep OSA could be more harmful to brain 
functioning than NREM sleep OSA. Previous authors have suggested that the harmful 
impact of REM sleep OSA could be due to the fact that respiratory events during REM 
sleep last longer and provoke more hypoxemia.15 In the present study, however, it was not 
the case. Apneas and hypopneas duration as well as mean and minimal saturation did not 
differ statistically between REM and NREM sleep in our sample. Instead, another 
hypothesis could be that the impact of REM sleep OSA could be related to the 
physiological response to apneas and hypopneas rather than their characteristics like 
duration and oxygen saturation. Compared to NREM sleep, REM sleep is characterized by 
a high level of brain activity, higher sympathetic activity, and irregular heart rate.34, 35 
These REM sleep particularities could put the brain in a vulnerable state to the effects of 
OSA. In fact, blood pressure fluctuations are higher for apneas and hypopneas during REM 
sleep than NREM sleep.16 Moreover, increased activity during REM sleep has been 
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previously reported for the ventral and orbital prefrontal cortex as well as for the anterior 
portion of the insula.36 Areas with increased metabolic requirements during apneas and 
hypopneas could be more susceptible to injury provoked by oxygen shortage, arousals, and 
hemodynamic fluctuations. These areas of high activity during REM sleep could show 
neuronal dysfunction that can then be manifested during daytime as reduced activity. Thus, 
OSA during REM sleep could lead to vascular and metabolic consequences to which the 
brain is especially vulnerable. Consistently, OSA during REM sleep was recently 
associated with impaired cardiovascular and metabolic function.17-21. 
Because we observed larger and more regions of reduced rCBF, our analyses were stronger 
when using the absolute number of apneas and hypopneas during REM sleep rather than the 
REM-AHI. This could be due to the exclusion of subjects with very short REM sleep 
duration in order to accurately compute the REM-AHI: indeed, subjects with very short 
REM sleep duration may be the ones that are most affected by OSA during REM sleep, 
which could be characterized by a perturbed and short REM sleep. Moreover, stronger 
results may also suggest that the absolute amount (AH) rather than the density (AHI) of 
apneas and hypopneas during REM sleep is more representative of underlying processes 
that may be detrimental to brain health. Overall, although the AHI is the standard 
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measurement of OSA severity, REM-AH may not be the best variable to assess REM sleep 
OSA giving the high influence of REM sleep duration on its value. 
Clinical significance of REM sleep OSA 
While some previous studies did not observe any association between OSA 
symptomatology and REM sleep OSA,9, 37, 38 others found that OSA during REM sleep was 
associated with depression.11, 12 Moreover, a study used a unique design in OSA individuals 
by applying CPAP during NREM sleep and removing it during REM sleep. They found 
that spatial navigation memory was impaired after this specific REM sleep disruption by 
OSA.39 In the present study, we found associations at a trend level between REM sleep 
OSA and worse cognitive performance in the complete sample and more depressive 
symptoms in subjects without moderate to severe OSA. Worse cognitive performance with 
REM sleep OSA was observed only in analyses that included the complete sample with all 
levels of OSA severity, where reduced rCBF in the ventromedial prefrontal cortex was also 
observed. The ventromedial prefrontal cortex may be involved in cognitive deficits 
associated with REM sleep OSA, since it is involved in various cognitive functions, 
including executive functions and memory.40 On the other hand, associations between REM 
sleep OSA and depressive symptoms were observed only in the subsample including 
subjects with a milder form of OSA, in whom reduced rCBF with a fronto-insular 
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distribution was also observed. Reduced insular perfusion may be involved in depressive 
symptoms because the insula is structurally included in the limbic system and plays a role 
in emotional behavior and feelings.41. These associations at a trend level between REM 
sleep OSA with a specific symptomatology may suggest that REM sleep OSA is more 
detrimental to brain health than NREM sleep OSA, for which no association was observed 
with symptomatology. Of note, only a fifth and a tenth of our sample showed cognitive 
deficits and mild depression levels, which may explain why only trends were observed. 
These trends obviously need to be replicated in a sample that is more symptomatic. 
Moreover, we did not observe any associations between OSA and daytime sleepiness. Our 
sample could be composed of OSA individuals with less clinical dysfunctions since a 
prevalence as high as 87 % for daytime sleepiness and 59 % for cognitive deficits were 
reported in other samples.42, 43 However, clinical dysfunctions were measured differently 
than in ours in these studies: excessive daytime sleepiness was considered as present when 
a mean sleep latency <10 was observed on the daytime Multiple Sleep Latency Test was 
observed, while cognitive deficits were identified with an impairment in one or more 
cognitive functions measured with a neuropsychological assessment.42, 43 
Although our sample was relatively asymptomatic, OSA is known to affect sleepiness, 
mood and cognition.7, 8 Thus, in addition to worse global cognitive performance and 
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depressive symptoms associated REM sleep OSA, various symptoms may arise from 
prolonged preclinical periods of neuronal dysfunction evidenced by areas of decreased 
daytime rCBF associated with REM sleep OSA. The ventromedial prefrontal cortex plays a 
key role in emotional processing and its dysfunction has been observed with mood, moral 
cognition and personality changes, and various psychiatric disorders.44, 45 The anterior 
insula is involved in a wide range of cognitive processes, including language, interoception 
and emotions.41 Although previous studies showed that OSA during NREM sleep was 
associated with sleepiness,13, 30, 46 we did not observe this relationship. However, prolonged 
preclinical periods of reduced perfusion in the parieto-temporal regions with NREM sleep 
OSA may also lead to various symptoms. In fact, sensorimotor and lateral temporal regions 
are involved in daytime sleepiness via their connection to the thalamus.47 The sensorimotor 
region and other parietal areas are constituents of the fronto-parietal attention network 
involved in working memory, episodic retrieval, and mental imagery48 while the lateral 
temporal cortex plays an important role in memory.49 Consequently, further studies should 
investigate whether changes in rCBF in these particular regions predict the occurrence of 
OSA symptomatology and decline in these cognitive functions.  
Therefore, abnormal rCBF in these specific cerebral areas may lead to symptoms following 
chronic REM or NREM sleep OSA over months or even years. However, the duration of 
 
 25 
the disease is difficult to assess in the OSA population. In fact, determining at which age 
the OSA condition started is very hard to know, since many people are not aware of their 
condition. OSA is often undiagnosed and asymptomatic, particularly in the elderly.50, 51 
Thus, although OSA was newly diagnosed in our sample, some individuals could have had 
OSA for years. Longitudinal studies are needed to understand the impacts of chronic and 
untreated OSA on the brain over time.  
As other authors have suggested,10, 18-20 we propose that individuals with several apneas and 
hypopneas during REM sleep, even with milder OSA forms, could benefit from treatment 
to reduce harmful effects to brain health. Consistently, continuous positive airway pressure 
(CPAP) was previously shown to be effective in reversing at least partially daytime rCBF 
changes in OSA individuals.4, 6 Moreover, many OSA patients treated with CPAP remove 
their mask before the end of the night, which is where most REM sleep occurs. This could 
lead to up to 60 % of REM sleep untreated with an average CPAP use.20 A poor CPAP 
adherence near the morning could make these treated patients vulnerable to the effects of 
OSA during REM sleep. This is problematic since subjects with OSA exclusively during 





Strengths and limitations 
To our knowledge, this is the first study to assess the specific effects of REM sleep OSA on 
brain health using neuroimaging. Our study adds to the current literature that underlines the 
detrimental effects of REM sleep OSA on physiological processes. The large sample 
investigated in this study, which included subjects with all levels of OSA severity, allowed 
us to investigate the specific effects of REM sleep OSA in milder cases.  
REM sleep OSA was shown to be more prevalent in younger individuals and women,13 two 
populations that are either not or only poorly represented in the present study. Nevertheless, 
sex was entered as a covariate in our additional analyses, and we found less but similar 
results.  
Conclusions  
We found that apneas and hypopneas during REM versus NREM sleep were associated 
with distinct patterns of daytime regional cerebral perfusion, with a hypoperfused 
ventromedial prefrontal and fronto-insular distribution associated with REM sleep OSA as 
well as a hypoperfused left sensorimotor and temporal cortex associated with NREM sleep 
OSA. Only REM sleep OSA was independently associated with altered rCBF during 
wakefulness in subjects with a milder OSA forms. Our results suggest that OSA during 
REM sleep could be more detrimental to brain health. Therefore, subjects with OSA 
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predominantly during REM sleep, but with low overall OSA severity could benefit from 
treatment. As suggested by others,10, 18-20 prolonged use of CPAP therapy throughout the 
night may also be beneficial, as most REM sleep occurs near morning. However, before 
justifying treatment for all REM sleep predominant OSA patients, our results need to be 
replicated in longitudinal treatment studies to obtain a more complete understanding of the 
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Figure 1. Daytime brain perfusion patterns associated with OSA during REM versus 
NREM sleep. 
In the complete sample representing all OSA severities (n=96, AHI from 0 to 97, model 1), 
reduced daytime rCBF is associated with A) a higher REM-AH in the bilateral 
ventromedial prefrontal cortex and right insula extending to the frontal cortex; B) a higher 
NREM-AH in the left sensorimotor and lateral temporal cortex. Regressions model were 
between REM-AH and daytime rCBF, adjusted for age, total sleep duration and NREM-
AH (A); and between NREM-AH and daytime rCBF, adjusted for age, total sleep duration 
and REM-AH (B). Statistical analyses were performed on every voxel of gray matter. 
Significant regions of abnormal rCBF were identified when single voxels showed a 
significant regression with the OSA variable (statistical threshold at p<0.001) and when 
these were surrounded by a cluster of >100 voxels with rCBF values that behave similarly. 
Similar regions of daytime hypoperfusion were observed when REM-AHI and NREM-AHI 
were used instead of REM-AH and NREM-AH. rCBF, regional cerebral blood flow; 
NREM, non-rapid eye movement sleep; REM, rapid eye movement sleep; AH, apneas + 





Table 1. Clinical, polysomnographic, and respiratory variables for healthy control subjects 










p-value Post-hoc tests 
AHI criteria for groups  <5 ≥5 to <15 ≥15 to <30 ≥30 n/a  
Number of subjects 16 37 20 23 n/a  
Sex (#; %Male) 10; 62.5% 24; 64.9% 17; 85.0% 20; 87.0% ns  
Age (years) 64.4 (6.7) 64.4 (5.9) 64.6 (6.3) 67.0 (7.0) ns  
Body Mass Index (kg/m2) 25.9 (3.4) 26.7 (3.6) 28.9 (3.6) 28.6 (2.5) <0.05 A <C 
Vascular Burden Index 0.9 (1.1) 1.3 (1.4) 1.3 (1.0) 1.4 (1.3) ns  
Epworth Sleepiness Scale 7.8 (5.7) 7.5 (4.6) 9.1 (5.2) 8.4 (4.8) ns  
Beck Depression Inventory II 5.4 (5.4) 6.4 (5.4) 7.1 (5.4) 7.0 (5.2) ns  
Beck Anxiety Inventory 4.7 (4.7) 4.0 (4.0) 5.2 (5.7) 4.1 (4.1) ns  
Montreal Cognitive Assessment 27.4 (2.2) 27.6 (2.0) 27.2 (2.4) 26.5 (3.0) ns  
Polysomnographic variables      
TST (min) 367.0 (54.9) 358.7 (74.0) 347.1 (49.1) 370.5 (62.6) ns  
Sleep efficiency (%) 78.4 (8.8) 79.1 (12.5) 78.7 (11.2) 79.2 (11.0) ns  
MAI (MA/hour) 11.1 (4.0) 13.5 (5.4) 17.0 (6.6) 23.8 (10.8) <0.001 A, B, C <D 
NREM 1 (min) 58.5 (28.1) 62.4 (23.3) 78.3 (30.5) 121.0 (51.7) <0.001 A, B, C <D 
NREM 2 (min) 209.7 (44.2) 197.7 (61.6) 196.7 (47.6) 180.8 (57.5) ns  
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NREM 3 (min) 40.3 (31.7) 41.4 (39.0) 21.1 (24.5) 16.3 (18.7) <0.01 B >D 
NREM (min) 308.5 (52.9) 301.4 (60.1) 296.0 (42.7) 318.1 (54.6) ns  
NREM (%) 83.9 (4.6) 84.5 (5.5) 85.5 (5.7) 86.0 (5.7) ns  
REM (min) 58.5 (16.5) 57.2 (24.0) 51.0 (20.5) 52.3 (24.3) ns  
REM duration <30 (%) 0.0% 13.5% 20.0% 13.0% ns  
REM (%) 16.1 (4.6) 15.5 (5.5) 14.5 (5.7) 14.0 (5.7) ns  
Respiratory variables       
AHI (AH/hour) 2.0 (1.3) 9.3 (2.8) 22.3 (4.6) 46.6 (17.9) <0.001 A <B <C <D 
AH duration (s) 20.3 (5.2) 22.3 (4.6) 20.7 (3.6) 25.9 (5.2) <0.001 A, B, C <D 
NREM-AHI (AH/hour) 1.4 (1.2) 7.5 (3.5) 20.3 (5.9) 46.5 (18.2) <0.001 A, B <C <D 
#NREM-AH 6.8 (5.5) 37.0 (18.8) 101.1 (37.1) 246.0 (107.7) <0.001 A, B <C <D 
REM-AHI (AH/hour) 5.4 (5.1) 22.7 (22.2) 40.1 (28.2) 49.5 (30.2) <0.001 A <C, D; B <D 
#REM-AHI  5.3 (5.4) 18.0 (14.1) 28.2 (17.0) 38.0 (22.4) <0.001 A <B, C, D; B<D 
Minimal SpO2 (%) 90.4 (2.9) 87.0 (4.5) 82.9 (5.6) 82.5 (5.5) <0.001 A, B >C, D 
Minimal NREM SpO2 (%) 91.3 (2.9) 88.2 (4.6) 84.1 (5.8) 83.9 (4.8) <0.001 A, B >C, D 
Minimal REM SpO2 (%) 91.4 (2.3) 89.6 (3.5) 85.2 (6.3) 84.7 (6.1) <0.001 A, B >C, D 
TST SpO2 <90% (min) 0.1 (0.2) 2.1 (5.1) 6.0 (5.1) 16.1 (18.9) <0.001 A, B, C <D 
Results are presented as mean (SD). OSA, obstructive sleep apnea; AHI, apnea-hypopnea index; N/A, not 
applicable; TST, Total sleep time; MAI, micro-arousal index; NREM, non-rapid eye movement sleep; REM, 










Peak location with AAL atlas  
x y z 
Model 1: Reduced daytime rCBF with REM-AH 
647*† 4.6 -12 62 2 L superior frontal medial 
 4.0 6 54 -8 R medial orbitofrontal 
221* 4.1 42 20 4 R inferior frontal pars triangularis 
(extending to the R insula) 
Model 1: Reduced daytime rCBF with NREM-AH 
140 4.1 -68 -16 -20 L middle temporal 
 3.8 -68 -26 -20 L inferior temporal 
225† 3.9 -66 -14 22 L postcentral (parietal) 
 3.9 -66 -16 30 L postcentral (parietal) 
 3.9 -64 -20 38 L supramarginal (parietal) 
Model 2: Reduced daytime rCBF with REM-AH in subjects with AHI<15 
271*† 4.4 40 18 6 R inferior frontal pars opercularis 
(extending to the R insula) 
100 3.9 -30 22 10 L insula 
Regression models included both REM-AH and NREM-AH as well as age and total sleep duration as 
covariates. Clusters marked with (*) were still significant when sex was added as a covariate (cluster size: 
146, 133 and 200 voxels). Clusters marked with (†) were still significant with REM-AHI or NREM-AHI 
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instead of REM-AH and NREM-AH in subjects with REM sleep duration ≥ 30 minutes (cluster size: 207, 193 
and 185 voxels). Significant regions of daytime rCBF were obtained with the following threshold: p <0.001 
uncorrected for peaks voxels found within a cluster of >100 continuous voxels. rCBF, regional cerebral blood 
flow; NREM, non-rapid eye movement sleep; REM, rapid eye movement sleep; AH, apneas + hypopneas; 
AHI; apnea-hypopnea index; MNI, Montreal Neurological Institute; AAL, Automated Anatomical Labeling; 
OSA, obstructive sleep apnea; L, left; R, right. 
 
 
 
 
 
 
